
Azius Pharma Private Limited
About Azius Pharma Private Limited
Data last updated:
Azius Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 26 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC325344. Its GSTIN is 07AAQCA1691L1Z6 (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Mohammad Azaz Ahmad and Afrin Faiz.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H – 26 Gali No – 8 Old Govind Pura Old Govind Pura Extn Near Shop, New Delhi, Delhi, India – 110051.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.96 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹5.02 Lakh (net margin 1.7%) and EBITDA of ₹7.3 Lakh (EBITDA margin 2.5%). Revenue has grown at a compounded annual rate (CAGR) of 61% over three years and 115% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH – 26 Gali No – 8 Old Govind Pura Old Govind Pura Extn Near Shop, New Delhi, Delhi, India – 110051
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Azius Pharma Private Limited
The main business activity of Azius Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Azius Pharma Private Limited FY 2025 filings available
Azius Pharma Private Limited reported revenue of ₹2.96 Cr (up 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Azius Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 115% over five years, including 26% growth in the latest year. EBITDA rose 68% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Azius Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹7.3 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹5.02 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Azius Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Azius Pharma are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Azius Pharma Private Limited
Azius Pharma Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Formulations, Medical and Laboratory Equipment). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Realmed Pharma Private Limited | ₹2.99 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Chandigarh, India |
| Spectrum Pharmachem Private Limited | ₹2.99 Cr (FY 2024) | •••• | •••• | 1495500.0% | •••• | Palghar, Maharashtra, India |
| Fuzen Pharmaceuticals Private Limited | ₹2.98 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Indore, Madhya Pradesh, India |
| Ace Ortho Care Private Limited | ₹2.96 Cr (FY 2025) | •••• | •••• | -42.0% | •••• | New Delhi, Delhi, India |
| Progenerics Pharma Private Limited | ₹2.96 Cr (FY 2025) | •••• | •••• | 70.0% | •••• | Patancheru, Telangana, India |
| Azius Pharma Private Limited this company | ₹2.96 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | New Delhi, Delhi, India |
| Orionex Formulations Private Limited | ₹2.96 Cr (FY 2025) | •••• | •••• | -30.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Protech Biopharma Private Limited | ₹2.96 Cr (FY 2025) | •••• | •••• | -39.0% | •••• | Srinagar, Jammu and Kashmir, India |
| Econ Life Science Private Limited | ₹2.96 Cr (FY 2025) | •••• | •••• | -28.0% | •••• | Kalol, Gujarat, India |
| Yava Medical Devices Private Limited | ₹2.95 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Mehsana, Gujarat, India |
| Yuvraj Biobiz Incubator India Private Limited | ₹2.95 Cr (FY 2024) | •••• | •••• | -30.0% | •••• | Tirupur, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Azius Pharma by revenue in the Healthcare industry (Formulations, Medical and Laboratory Equipment), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Azius Pharma Private Limited
Azius Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammad Azaz Ahmad Also directs: Asr Pharma (OPC) Private Limited | Director | 26 Oct 2017 | 8 Years 11 Months | Current |
| Afrin Faiz | Director | 26 Oct 2017 | 8 Years 11 Months | Current |
Ownership and Shareholding of Azius Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Azius Pharma Private Limited
Azius Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Azius Pharma Private Limited
Employment history and EPFO contributions of people linked to Azius Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Azius Pharma Private Limited
Azius Pharma Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Afrin Faiz was appointed as Director on 26 Oct 2017.
Credit Ratings, Litigation & Regulatory Alerts for Azius Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Azius Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Azius Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Azius Pharma Private Limited
Azius Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAQCA1691L1Z6 | Delhi | Active | 16 Mar 2019 |
| 10AAQCA1691L1ZJ | Bihar | Active | 11 Sep 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Azius Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Azius Pharma Private Limited
Azius Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in other services, within the business services industry. It was incorporated on 26 October 2017 (9+ years old) and is registered under CIN U74999DL2017PTC325344.
Azius Pharma reported revenue of ₹2.96 Cr for FY 2025 (up 26% YoY).
Azius Pharma has 2 current directors:
- Mohammad Azaz Ahmad - Director
- Afrin Faiz - Director
Azius Pharma reported a net profit of ₹5.02 Lakh (net margin 1.7%) and EBITDA of ₹7.3 Lakh (EBITDA margin 2.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Azius Pharma is 61% over three years and 115% over five years. In the latest year (FY 2025) revenue rose 26%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Azius Pharma is 07AAQCA1691L1Z6, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 10AAQCA1691L1ZJ (Bihar).
The CIN (Corporate Identification Number) of Azius Pharma is U74999DL2017PTC325344. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Azius Pharma was incorporated on 26 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Azius Pharma by revenue are Realmed Pharma Private Limited, Spectrum Pharmachem Private Limited, Fuzen Pharmaceuticals Private Limited, Ace Ortho Care Private Limited, Progenerics Pharma Private Limited and 5 more, all in the Healthcare industry (Formulations, Medical and Laboratory Equipment).
Afrin Faiz was appointed as Director on 26 Oct 2017. Mohammad Azaz Ahmad was appointed as Director on 26 Oct 2017.
The registered office of Azius Pharma is at H – 26 Gali No – 8 Old Govind Pura Old Govind Pura Extn Near Shop, New Delhi, Delhi, India – 110051.